Skip to main content

Adial Pharmaceuticals, Inc.

ADIL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001513525

In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in Adial Pharmaceuticals, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
26
+3 vs. Q1 2022
Shares held
1.70M
−1.47M (−46.5%) vs. Q1 2022
Total value
$2.27M
−$4.10M (−64.4%) vs. Q1 2022
New holders
7
7 more added
Sold out
4
3 more reduced

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ADIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 26 institutions
Q1 2021: 20 institutionsQ2 2021: 19 institutionsQ3 2021: 21 institutionsQ4 2021: 24 institutionsQ1 2022: 23 institutionsQ2 2022: 26 institutionsQ3 2022: 28 institutionsQ4 2022: 23 institutionsQ1 2023: 23 institutionsQ2 2023: 21 institutionsQ3 2023: 11 institutionsQ4 2023: 17 institutionsQ1 2024: 16 institutionsQ2 2024: 16 institutionsQ3 2024: 12 institutionsQ4 2024: 15 institutionsQ1 2025: 14 institutionsQ2 2025: 17 institutionsQ3 2025: 17 institutionsQ4 2025: 24 institutionsQ1 2026: 15 institutionsQ2 2026: 17 institutions
Value heldQ2 2022: $2.27M
Q1 2021: $1.95MQ2 2021: $3.15MQ3 2021: $5.50MQ4 2021: $3.64MQ1 2022: $6.38MQ2 2022: $2.27MQ3 2022: $692.1KQ4 2022: $359.2KQ1 2023: $876.9KQ2 2023: $488.2KQ3 2023: $164.2KQ4 2023: $500.0KQ1 2024: $236.2KQ2 2024: $328.0KQ3 2024: $195.9KQ4 2024: $298.1KQ1 2025: $152.7KQ2 2025: $70.8KQ3 2025: $214.8KQ4 2025: $778.4KQ1 2026: $63.8KQ2 2026: $334.6K
Institutions holding ADIL and their total value by quarter
QuarterHoldersValue
Q2 202617$334.6K
Q1 202615$63.8K
Q4 202524$778.4K
Q3 202517$214.8K
Q2 202517$70.8K
Q1 202514$152.7K
Q4 202415$298.1K
Q3 202412$195.9K
Q2 202416$328.0K
Q1 202416$236.2K
Q4 202317$500.0K
Q3 202311$164.2K
Q2 202321$488.2K
Q1 202323$876.9K
Q4 202223$359.2K
Q3 202228$692.1K
Q2 202226$2.27M
Q1 202223$6.38M
Q4 202124$3.64M
Q3 202121$5.50M
Q2 202119$3.15M
Q1 202120$1.95M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Adial Pharmaceuticals, Inc.; share changes are against Q1 2022.

Institutions holding ADIL in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc590,852$792.0K0.00%00.0%Unchanged
BlackRock Inc.224,910$301.0K0.00%−567−0.3%Reduced
Renaissance Technologies LLC169,400$227.0K0.00%+149,442+748.8%Added
Geode Capital Management, LLC135,889$182.0K0.00%+787+0.6%Added
Susquehanna International Group, LLP99,103$133.0K0.00%+80,986+447.0%Added
Raffa Wealth Management, LLC52,334$70.1K0.03%+10,489+25.1%Added
State Street Corp52,354$70.0K0.00%00.0%Unchanged
Millennium Management LLC39,490$53.0K0.00%+39,490New
Oppenheimer & Co Inc38,500$52.0K0.00%00.0%Unchanged
Commonwealth Equity Services, LLC36,461$48.0K0.00%00.0%Unchanged
Truist Financial Corp33,862$45.0K0.00%+33,862New
Virtu Financial LLC32,013$43.0K0.00%+32,013New
Northern Trust Corp29,705$40.0K0.00%+406+1.4%Added
Brown Advisory Inc26,040$35.0K0.00%00.0%Unchanged
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management25,000$34.0K0.00%−10,000−28.6%Reduced
Private Advisor Group, LLC21,400$29.0K0.00%−12,750−37.3%Reduced
Charles Schwab Investment Management Inc21,443$29.0K0.00%+21,443New
StoneX Group Inc.15,000$20.1K0.00%+15,000New
Jane Street Group, LLC13,854$19.0K0.00%+13,854New
Group One Trading, L.P.13,189$18.0K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.8,321$11.0K0.00%00.0%Unchanged
Simplex Trading, LLC7,723$10.0K0.00%+7,723New
Tower Research Capital LLC (TRC)6,590$9.00K0.00%+1,301+24.6%Added
Wells Fargo & Company996$1.00K0.00%+28+2.9%Added
Benjamin F. Edwards & Company, Inc.1,000$1.00K0.00%00.0%Unchanged
Morgan Stanley535$1.00K0.00%00.0%Unchanged
Armistice Capital, LLC0$00.00%−1,817,454−100.0%Sold out
Dimensional Fund Advisors LP0$00.00%−31,410−100.0%Sold out
UBS Group AG0$00.00%−6,840−100.0%Sold out
High Net Worth Advisory Group LLC0$00.00%−1,000−100.0%Sold out